Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a new class of drugs that might have a potential beneficial effect on bone metabolism. Data on the effect of GLP-1 RAs and fracture risk are lacking. The aim of the present study was to investigate the association between the use of GLP-1 and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Calcif Tissue Int
Egile Nagusiak: Driessen, Johanna H. M., van Onzenoort, Hein A. W., Starup-Linde, Jakob, Henry, Ronald, Burden, Andrea M., Neef, Cees, van den Bergh, Joop P., Vestergaard, Peter, de Vries, Frank
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer US 2015
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4598352/
https://ncbi.nlm.nih.gov/pubmed/26184119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-015-0037-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak